Evolution of Liver Transplantation

HepatologyVolume 2, Issue 5 p. 614S-636S ArticleFree Access Evolution of Liver Transplantation Thomas E. Starzl, Thomas E. Starzl Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorShunzaburo Iwatsuki, Shunzaburo Iwatsuki Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorDavid H. Van Thiel, David H. Van Thiel Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorJ. Carlton Gartner, J. Carlton Gartner Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorBasil J. Zitelli, Basil J. Zitelli Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorJ. Jeffrey Malatack, J. Jeffrey Malatack Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorRobert R. Schade, Robert R. Schade Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorByers W. , Shaw Jr ., Byers W. , Shaw Jr . Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorThomas R. Hakala, Thomas R. Hakala Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorJ. Thomas Rosenthal, Corresponding Author J. Thomas Rosenthal Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandThomas E. Starzl, M.D., Ph.D., Department of Surgery, University of Pittsburgh, 1084 Scaife Hall, Pittsburgh, Pennsylvania 15261.===Search for more papers by this authorKendrick A. Porter, Kendrick A. Porter Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this author Thomas E. Starzl, Thomas E. Starzl Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorShunzaburo Iwatsuki, Shunzaburo Iwatsuki Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorDavid H. Van Thiel, David H. Van Thiel Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorJ. Carlton Gartner, J. Carlton Gartner Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorBasil J. Zitelli, Basil J. Zitelli Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorJ. Jeffrey Malatack, J. Jeffrey Malatack Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorRobert R. Schade, Robert R. Schade Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorByers W. , Shaw Jr ., Byers W. , Shaw Jr . Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorThomas R. Hakala, Thomas R. Hakala Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this authorJ. Thomas Rosenthal, Corresponding Author J. Thomas Rosenthal Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandThomas E. Starzl, M.D., Ph.D., Department of Surgery, University of Pittsburgh, 1084 Scaife Hall, Pittsburgh, Pennsylvania 15261.===Search for more papers by this authorKendrick A. Porter, Kendrick A. Porter Departments of Surgery, Medicine, and Pediatrics, University of Pittsburgh Health Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and the Department of Pathology, Saint Mary's Hospital and Medical School, London, EnglandSearch for more papers by this author First published: September/October 1982 https://doi.org/10.1002/hep.1840020516Citations: 530AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Starzl TE, Marchioro TL, Von Kauila KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659– 676. 2 Starzl TE, Marchioro TL, Rowlands DT Jr., et al. Immunosuppression after experimental and clinical homotransplantation of the liver. Ann Surg 1964; 160: 411– 439. 3 Moore FD, Birtch AG, Dagher F, et al. Immunosuppression and vascular insufficiency in liver transplantation. Ann NY Acad Sci 1964; 102: 729– 738. 4 Demirleau, Noureddine, Vignes, et al. Tentative d'homogreffe hepatique (Attempted hepatic homograft). Mem Acad Chir (Paris) 1964; 90: 177– 179. 5 Starzl TE, Groth CT, Brettschneider L, et al. Orthotopic homo-transplantation of the human liver. Ann Surg 1968; 168: 392– 415. 6 Calne RY, Williams R. Liver transplantation in man-I, observations on technique and organization in five cases. Br Med J 1968; 4. 535– 540. 7 Williams R, Smith M, Shilkin KB, et al. Liver transplantation in man; the frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases. Gastroenterology 1973; 64: 1026– 1048. 8 Calne RY. Inhibition of the rejection of renal homografts in dogs by purine analogues. Transplantation Bull 1961; 28: 65. 9 Alper CA, Johnson AM, Birtch AG, et al. Human C′3: evidence for the liver as the primary site of synthesis. Science 1969; 163: 286– 288. 10 Birtch AG, Moore FD. Experiences in liver transplantation. Transplantation Rev 1969; 2: 90– 128. 11 Fonkalsrud EW, Stevens GH, Joseph WL, et al. Orthotopic liver allotransplantation using an internal vascular shunt. Surg Gynecol Obstet 1968; 127: 1051– 1057. 12 Daloze P, Delvin EE, Glorieux FH, et al. Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease Type A. Am J Med Genet 1977; 1: 221– 239. 13 Lie TS, Kauffer C, Siedek M, et al. Prolonged ischemic tolerance time of the human liver with successful grafting. Munch Med Wochenschr 1974; 116: 1013– 1020. 14 Bechtelsheimer H, Gedigk P, Muller R, et al. Pathologic anatomic observations after three orthotopic allogeneic transplantations of the liver in adults. Virchows Arch (Pathol Anat) 1973; 360: 287– 304. 15 Machado MD, Moneiro da Cunha JE, Margarido NF, et al. Hyperosmolar coma associated with clinical liver transplantation. Int Surg 1976; 61: 368– 369. 16 Abouna GM, Preshaw RM, Suva JLU, et al. Liver transplantation in a patient with cholangiocarcinoma and ulcerative colitis. Can Med Assoc J 1976; 115: 615– 619. 17 Fortner JG, Beattie EJ Jr., Shiu MH, et al. Orthotopic and heterotopic liver homografts in man. Ann Surg 1970; 172: 23– 32. 18 Hume DM, Wolf JS, Lee HM, et al. Liver transplantation. Transplant Proc 1972; 4: 781– 784. 19 Lampe EW, II, Simmons RL, Najarian JS. Hyperglycemic nonketotic coma after liver transplantation. Arch Surg 1973; 105: 774– 776. 20 Orr WM, Charlesworth D, Mallick NP, et al. Liver transplantation in man after an extended period of preservation by a simple technique. Br Med J 1969; 4: 28– 30. 21 Aune S, Schistad G, Skulberg A. Human liver transplantation without azathioprine. Surg Gynecol Obstet 1972; 135: 727– 728. 22 Gips CH, Krom RA, de Groot EH, et al. The fate of 30 patients for whom liver transplantation was considered during the period 1977 to 1979 included, and actually performed in 7 of them. Ned Tijdschr Geneeskd 1981; 125: 868– 874. 23 Wolff H, Otto G, Hoffman H. Liver transplantation in the German Democratic Republic. Khirurgiia (Musk) 1981; 10: 64– 69. 24 Pichlmayr R, Brolsch CHE, Tidow G, et al. Liver transplants: current status. Sereno Symposium London 1980; 34: 335– 342. 25 Brölsch CHE, Neuhaus P, Pichlmayr R. Gegenwartiger Stand der Leber–Transplantation. Z Gastroenterologie 1982; 20: 117– 122. 26 Houssin D, Franco D, Corlette MB, et al. Criteria for hepatic transplantation in cirrhosis. Surg Gynecol Obstet 1980; 151: 30– 32. 27 Cannon JA. Transplantation Bull 1956; 3: 7. 28 Moore FD, Wheeler HB, Demissianos HV, et al. Experimental whole-organ transplantation of the liver and of the spleen. Ann Surg 1960; 152: 374– 387. 29 Starzl TE, Kaupp HA, Brock DR, et al. Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow. Surg Gynecol Obstet 1960; 111: 733– 743. 30 Starzl TE, Kaupp HA, Brock DR, et al. Studies on the rejection of the transplanted homologous dog liver. Surg Gynecol Obstet 1961; 112: 135– 144. 31 Groth CG, Porter KA, Otte JB, et al. Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery 1968; 63: 658– 668. 32 Starzl TE (with the assistance of Putnam CW). Experience in hepatic transplantation. Philadelphia: W. B. Saunders Co., 1969. 33 Starzl TE, Marchioro TL, Porter KA, et al. Factors determining short- and long-term survival after orthotopic liver homotransplantation in the dog. Surgery 1965; 58: 131– 155. 34 Mikaeloff P, Dureau G, Rassat JP, et al. Orthotopic transplantation of the liver in dogs. II. Immunosuppressive treatment (Imuran and Actinomycin C). Ann Chir Thorac Cardiovasc 1965; 4: 649– 662. 35 Starzl TE, Marchioro TL, Faris TD, et al. Avenues of future research in homotransplantation of the liver: with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing. Am J Surg 1966; 112: 391– 400. 36 Starzl TE, Marchioro TL, Porter KA, et al. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet 1967; 124: 301– 318. 37 Mikaeloff P, Pichlmayr R, Rassat JP, et al. Orthotopic homotransplantation of the liver in the dog: immunosuppressive treatment with antilymphocyte serum. Presse Med 1967; 75: 1967– 1970. 38 Birtch AG, Orr WM, Duquella J. Evaluation of horse anti-dog antilymphocyte globulin in the treatment of hepatic allografts. Surg Forum 1968; 19: 186– 188. 39 Starzl TE, Porter KA, Putnam CW. Eleven and two-thirds years survival after canine orthotopic liver transplantation. Transplantation 1977; 23: 168– 171. 40 Gamier H, Clot JP, Bertrand M, et al. Liver transplantation in the pig: surgical approach. C R Seances Acad Sci (Paris) 1965; 260: 5621– 5623. 41 Peacock JH, Terblanche J. Orthotopic homotransplantation of the liver in the pig. In: AE Read, ed. The liver. London: Butter-worth & Co., Ltd., 1967: 333– 336. 42 Calne RY, White HJO, Yoffa DE, et al. Prolonged survival of liver transplants in the pig. Br Med J 1967; 4: 645– 648. 43 Starzl TE, Porter KA, Putnam CW, et al. Orthotopic liver transplantation in 93 patients. Surg Gynecol Obstet 1976; 142: 487– 505. 44 Starzl TE, Schneck SA, Mazzoni G, et al. Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg 1978; 187: 236– 240. 45 Starzl TE, Koep LJ, Halgrimson CG, et al. Fifteen years of clinical liver transplantation. Gastroenterology 1979; 77: 375– 388. 46 Starzl TE, Koep LJ, Weil R, III, et al. Development of a supra-hepatic recipient vena cava cuff for liver transplantation. Surg Gynecol Obstet 1979; 149: 76– 77. 47 Calne RY. Surgical aspects of clinical liver transplantation in 14 cases. Br J Surg 1969; 56: 729– 736. 48 Calne RY. A new technique for biliary drainage in orthotopic liver transplantation utilizing the gallbladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg 1976; 184: 605– 609. 49 Calne RY, Williams R. Orthotopic liver transplantation: the first 60 patients. Br Med J 1977; 1: 471– 476. 50 Calne RY, McMaster P, Portmann B, et al. Observations on preservation, bile drainage and rejection. Ann Surg 1977; 186: 282– 290. 51 Calne RY, Williams R. Liver transplantation. Curr Probl Surg 1979; 16: 3– 44. 52 Calne RY, McMaster P, Smith DP, et al. Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet 1979; 2: 612– 614. 53 Calne RY, Williams R, Lindop M, et al. Improved survival after orthotopic liver grafting. Br Med J 1981; 283: 115– 118. 54 von Kaulla KN, Kaye H von Kaulla E, et al. Changes in blood coagulation before and after hepatectomy or transplantation in dogs and men. Arch Surg 1966; 92: 71– 79. 55 Groth CG, Pechet L, Starzl TE. Coagulation during and after orthotopic transplantation of the human liver. Arch Surg 1969; 98: 31– 34. 56 Iwatsuki S, Popovtzer M, Corman J, et al. Recovery from “hepatorenal syndrome” after orthotopic liver transplantation. N Engl J Med 1973; 289: 1155– 1159. 57 Benichou J, Halgrimson CG, Weil R, III, et al. Canine and human liver preservation for 6–18 hours by cold infusion. Transplantation 1977; 24: 407– 411. 58 Wall WJ, Calne RY, Herbertson BM, et al. Simple hypothermic preservation for transporting human livers long distances for transplantation. Transplantation 1977; 23: 210– 216. 59 Shaw BW Jr., Hakala T, Rosenthal JT, et al. Combination donor hepatectomy and nephrectomy and early function results of allografts. Surg Gynecol Obstet 1982; 155: 321– 325. 60 Pappas G, Palmer WM, Martineau GL, et al. Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery 1971; 70: 872– 875. 61 Picache RS, Kapur BML, Starzl TE. The effect of liver disease on the need for venous decompression during the anhepatic phase of canine orthotopic liver transplantation. Surgery 1970; 67: 319– 321. 62 Martineau G, Porter KA, Corman J, et al. Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery 1972; 72: 604– 610. 63 Starzl TE, Porter KA, Putnam CW, et al. Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery 1976; 81: 213– 221. 64 Terblanche J, Koep LJ, Starzl TE. Liver transplantation. Med Clin North Am 1979; 63: 507– 521. 65 Waddell WR, Grover FL. The gallbladder as a conduit between the liver and intestine. Surgery 1973; 74: 524– 529. 66 Iwatsuki S, Iwaki Y, Kano T, et al. Successful liver transplantation from cross match positive donors. Transplant Proc 1981; 13: 286– 288. 67 Starzl TE. Experience in renal transplantation. Philadelphia: W. B. Saunders Co., 1964. 68 Murray JE, Merrill JP, Dammin GJ, et al. Study on transplantation immunity after total body irradiation: clinical and surgical investigation. Surgery 1960; 48: 272– 284. 69 Murray JE, Merrill JP, Dammin GH, et al. Kidney transplantation in modified recipients. Ann Surg 1962; 156: 337– 355. 70 Starzl TE, Marchioro TL, Waddell WR. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963; 117: 656– 676. 71 Hume DM, Magee JH, Kauffman HM, et al. Renal transplantation in man in modified recipients. Ann Surg 1963; 158: 608– 644. 72 Murray JE, Merrill JP, Harrison JH, et al. Prolonged survival of human kidney homografts with immunosuppressive drug therapy. N Engl J Med 1963; 268: 1315– 1323. 73 Woodruff MFA, Robson JS, Nolan B, et al. Homotransplantation of kidney in patients treated by preoperative local radiation and postoperative administration of an antimetabolite (Imuran). Lancet 1963; 2: 675– 682. 74 Opelz G, Mickey MR, Terasake PI. HLA matching and cadaver transplant survival in North America. Transplantation 1977; 23: 490– 497. 75 McDonald JC, Vaughn W, Filo RS, et al. Cadaver donor renal transplantation by centers of the southeastern organ procurement foundation. Ann Surg 1981; 193: 1– 8. 76 Starzl TE, Putnam CW, Halgrimson CG, et al. Cyclophosphamide and whole organ transplantation in humans. Surg Gynecol Obstet 1971; 133: 981– 991. 77 Franksson C. Survival of homografts of skin in rats depleted of lymphocytes by chronic drainage from the thoracic duct. Lancet 1964; 1: 1331– 1332. 78 Starzl TE, Weil R, III, Koep LJ, et al. Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet 1979; 149: 815– 821. 79 Starzl TE, Klintmalm GBG, Iwatsuki S, et al. Late follow-up after thoracic duct drainage in cadaveric renal transplantation. Surg Gynecol Obstet 1981; 153: 377– 382. 80 Starzl TE, Koep L, Porter KA, et al. Decline in survival after liver transplantation. Arch Surg 1980; 115: 815– 819. 81 Strober S, Slavin S, Fuks Z, et al. Transplantation tolerance after total lymphoid irradiation. Transplant Proc 1979; 11: 1032– 1038. 82 Najarian JS, Sutherland DER, Ferguson RM, et al. Fractional total lymphoid irradiation (TLI) as preparative immunosuppression in high risk renal transplantation. Ann Surg 1982; 196: 442– 452. 83 Borel JF, Feurer C, Gubler HU, et al. Biological effects of cyclosporin A; a new antilymphocytic agents. Agents Actions 1976; 6: 468– 475. 84 Borel JF, Feurer C, Magnee C, et al. Effects of the new antilymphocytic peptide cyclosporin A in animals. Immunology 1977; 32: 1017– 1025. 85 Kostakis AJ, White DJG, Calne RY. Prolongation of rat heart allograft survival by cyclosporin A. IRCS Med Sci 1977; 5: 280. 86 Calne RY, White DJG. Cyclosporin A A powerful immunosuppressant in dogs with renal allografts. IRCS Med Sci 1977; 5: 595. 87 Calne RY, White DJG, Rolles K, et al. Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet 1978; 1: 1183– 1185. 88 Calne RY, White DJG, Pentlow BD, et al. Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc 1979; 11: 860– 864. 89 Green CJ, Allison AC. Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin A treatment. Lancet 1978; 1: 1182– 1183. 90 Calne RY, White DJH, Thiru S, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; 2: 1323– 1327. 91 Calne RY, Rolles K, White DJG, et al. Cyclosporin A initially as the only immunosuppressant in 34 patients of cadaveric organs; 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979; 2: 1033– 1036. 92 Starzl TE, Weil R, III, Iwatsuki S, et al. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980; 151: 17– 26. 93 Starzl TE, Klintmalm GBG, Weil R, III, et al. Cyclosporin A and steroid therapy in 66 cadaver kidney recipients. Surg Gynecol Obstet 1981; 153: 486– 494. 94 Calne RY, White DJG, Evans DB, et al. Cyclosporin A in cadaveric organ transplantation. Br Med J 1981; 282: 934– 936. 95 Carpenter BJ, Tilney NL, Strom TB, et al. Cyclosporin A in cadaver renal allografts. Kidney Int 1981; 19: 265. 96 Sweny P, Farrington K, Younis F, et al. Sixteen months experience with cyclosporin A in human kidney transplantation. Transplant Proc 1981; 13: 365– 367. 97 Starzl TE, Hakala TR, Rosenthal JT, et al. Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids. Surg Gynecol Obstet 1982; 154: 819– 825. 98 Powles RJ, Clink HM, Spence D. Cyclosporin A to prevent graft-versus-host disease in man after allogenic bone-marrow transplantation. Lancet 1980; 1: 327– 329. 99 Klintmalm GBG, Iwatsuki S, Starzl TE. Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1981; 1: 470– 471. 100 Keown PA, Stiller CR, Ulan RA, et al. Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet 1981; 1: 686– 689. 101 Rynasiewicz JJ, Sutherland DER, Simmons RL, et al. Cyclosporin A for the oliguric renal transplantation patient. Lancet 1981; 1: 276. 102 Kahan BD, Van Buren CT, Lin SN, et al. Immunopharmacologic monitoring of cyclosporin A treated recipients of cadaveric kidney allografts. Transplantation 1982; 34: 36– 45. 103 Klintmalm GBG, Iwatsuki S, Starzl TE. Cyclosporin A nepauoioxicity in 66 renal allograph recipients. Transplantation 1981; 32: 488– 489. 104 Penn I. Tumor incidence in human allograft recipients. Transplant Proc 1979; 11: 1047– 1051. 105 Starzl TE, Groth CW, Putnam J, et al. Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc 1973; 1: 511– 516. 106 Calne RY, Rolles K, White DJG, et al. Cyclosporin A in clinical organ grafting. Transplant Proc 1981; 13: 349– 358. 107 Starzl TE, Iwatsuki S, Klintmalm G, et al. Liver transplantation 1980, with particular reference to cyclosporin A. Transplant Proc 1981; 13: 281– 285. 108 Starzl TE, Klintmalm GBG, Weil R, III, et al. Liver transplantation with use of cyclosporin A and prednisone. N Engl J Med 1981; 305: 266– 269. 109 Starzl TE, Iwatsuki S, Bahnson HB, et al. Cyclosporin A and steroids for liver and heart transplantation. In: Proceedings of International Symposium of Cyclosporin A, Cambridge, England. Amsterdam: Elsevier/North-Holland Biomedical Press, 1982. 110 Porter KA. Pathology of liver transplantation. Transplant Rev 1969; 2: 129– 170. 111 Myburgh JA, Abrahams C, Mendelsohn D, et al. Cholestatic phenomenon in hepatic allograft rejection in the primate. Transplant Proc 1971; 3: 501– 504. 112 Limmer J, Herbertson BM, Calne RY. Orthotopic rat liver transplantation using different combinations of 4 inbred strains. Eur Surg Res 1980; 12: 343– 348. 113 Herbertson BM. Pathology of liver transplants. In: RY Calne, ed. Clinical organ transplantations. Oxford: Blackwell Scientific Publications, 1971. 114 Portmann B, Williams R. Histopathology of the transplanted liver. In: R Williams, L Cantoni, eds. Recenti progressi in epatologia. Milan: Casa Editrice Ambrosiana, 1979: 369– 381. 115 Hunt AC. Pathology of liver transplantation in the pig. In: AE Read, ed. The liver. London: Butterworths, 1967: 337– 349. 116 Fennell RH, Roddy HJ. Liver transplantation: the pathologist's perspective. Pathol Ann 1979; 14 (Part 2): 155– 182. 117 Andres GA, Accini L, Ansell ID, et al. Immunopathologic studies of orthotopic human liver allografts. Lancet 1972; 1: 275– 280. 118 Brettschneider L, Tong J, Boose DS, et al. Specific bacteriologic problems with canine orthotopic liver transplantation. Arch Surg 1968; 97: 313– 322. 119 Fulginiti VA, Scribner R, Groth CG, et al. Infections in recipients of liver homografts. N Engl J Med 1968; 279: 619– 626. 120 Schroter GPJ, Hoelscher M, Putnam CW, et al. Infections complicating orthotopic liver transplantation: with emphasis on graft related septicemia. Arch Surg 1976; 111: 1337– 1347. 121 Schroter GPJ, Hoelscher M, Putnam CS, et al. Fungus infections after liver transplantation. Ann Surg 1977; 186: 115– 122. 122 Calne RY. Liver transplantation for liver cancer. World J Surg 1982; 6: 76– 80. 123 Starzl TE, Putnam CWK, Ishikawa M, et al. Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. N Y Acad Sci 1975; 252: 145– 158. 124 Iwatsuki W, Klintmalm GBG, Starzl TE. Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg 1982; 6: 81– 85. 125 Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 46: 372– 379. 126 Berman MM, Libbey NP, Foster JH. Hepatocellular carcinoma; polygonal cell type with fibrous stroma–An atypical variant with a favorable prognosis. Cancer 1980; 46: 1448– 1455. 127 Dubois RS, Giles G, Rodgerson DO, et al. Orthotopic liver transplantation for Wilson's disease. Lancet 1971; 1: 505– 508. 128 Groth CG, Dubois RS, Corman J, et al. Metabolic effects of hepatic replacement in Wilson's disease. Transplantation Proc 1973; 5: 829– 833. 129 Putnam CW, Porter KA, Peters RL, et al. Liver replacement for alpha-1-antitrypsin deficiency. Surgery 1977; 81: 258– 261. 130 Hood JM, Koep LJ, Peters RL, et al. Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med 1980; 302: 272– 275. 131 Fisch RO, McCabe ERB, Doeden D, et al. Homotransplantation of the liver in a patient with hepatoma in hereditary tyrosinemia. J Pediatr 1978; 93: 592– 596. 132 Starzl TE, Iwatsuki S, Malatck JJ, et al. Liver and kidney transplantation in children under cyclosporin A and steroids. J Pediatr 1982; 5: 681– 686. 133 Corman JL, Putnam CW, Iwatsuki S, et al. Liver homotransplantation for chronic aggressive hepatitis, Australia antigen positive. Arch Surg 1979; 114: 75– 78. 134 Johnson PJ, Wansbrough-Jones MH, Portmann B, et al. Familial HBsAg positive hepatoma: treatment with orthotopic liver transplantation an specific immunoglobul. Br Med J 1978; 1: 216. 135 Neuberger J, Portmann B, Macdougall BR, et al. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982; 306: 1– 4. 136 Fortner JG, Yeh SDJ, Kim DK, et al. The case for and technique of heterotopic liver grafting. Transplant Proc 1979; 11: 269– 275. 137 Houssin D, Berthelot P, Franco D, et al. Heterotopic liver transplantation in end-stage HBsAg-positive cirrhosis. Lancet 1980; 1: 990– 993. 138 Marchioro TL, Porter KA, Dickinson TC, et al. Physiologic requirements for auxiliary liver homotransplantation. Surg Gynecol Obstet 1965; 121: 17– 31. 139 Starzl TE, Terblanche J. Hepatotrophic substances. In: H Popper, F Schaffner, eds. Progress in liver diseases. Vol V. New York: Grune & Stratton, 1979: 135– 152. 140 O'Donnell TF, Gembarowica RM, Callow AD, et al. The economic impact of acute variceal bleeding: cost-effectiveness implications for medical and surgical therapy. Surgery 1980; 88: 693– 701. 141 Kashiwagi N. Special immunochemical studies. In: TE Starzl, ed. Experience in hepatic transplantation. Philadelphia: W. B. Saunders Co., 1969: 394– 407. 142 Alper CA, Raum D, Audeh Z, et al. Studies of hepatic synthesis in vivo of plasma proteins including orosomucoid, transferrin, alpha-1-antitrypsin C 8 and Factor B. Clin Immunol Immunopathol 1980; 16: 84– 89. 143 Raum D, Marcus DM, Alper CA, et al. Synthesis of human plasminogen by the liver. Science 1980; 208: 1036– 1037. Citing Literature Volume2, Issue5September/October 1982Pages 614S-636S ReferencesRelatedInformation